
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare is positioned for strong growth in the coming years, with a potential 10% sequential increase in EBITDA in the first quarter of 2026 and significant potential for organic growth. The company is generating a large amount of cash, with potential for close to 50% of its market cap in the next three years. While there are potential headwinds, such as the expiration of HIX subsidies, Tenet has put itself in a strong position through its business transformation, deleveraging, and performance.
Bears say
Tenet Healthcare is facing cost reduction initiatives, minimal organic growth, and dependence on higher margin USPI business, which raises concerns about its financial stability and competitiveness in a changing healthcare industry. Additionally, the deferral of revenue and high levels of M&A activity also pose risk. While the company may benefit from favorable industry trends, it may face challenges in achieving sustained growth and profitability.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares